HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.

AbstractBACKGROUND:
5-HT(1A)-R-agonist repinotan was shown to counteract a morphine-induced ventilatory depression but had pronociceptive effects at small doses (0.2 μg/kg). It remained to be clarified (1) whether a moderate dose of repinotan, sufficient to stimulate spontaneous breathing, impairs antinociception if plasma concentration decreases over time, and if (2) moderate doses prevent ventilatory depression if given before the opioid.
METHODS:
A dose-response curve of the repinotan effects on spontaneous minute ventilation during continuous remifentanil infusion in anesthetized rats was established to identify moderate doses: (1) tail-flick reflex latencies to assess nociception were recorded until 60 min after cessation of a continuous remifentanil infusion with or without a concomitant moderate repinotan dose (10 μg/kg), and (2) remifentanil boluses (2.5 μg/kg) were given after repinotan (10 and 20 μg/kg).
RESULTS:
(1) Remifentanil-induced antinociception lasted only 5 min after infusion was stopped (tail-flick reflex latencies; median [interquartile range], 97 [54-100]% of maximum possible effect; P = 0.034), but was extended by repinotan (10 μg/kg) to 30 min (tail-flick reflex latencies, 100 [75-100]% of maximum possible effect; P = 0.031). Repinotan (10 μg/kg) alone did not have any significant antinociceptive effect. (2) The ventilatory depression by remifentanil boluses (2.5 μg/kg; minute ventilation, -65 [-81 to -56]%; P = 0.031, n = 5) was blunted by repinotan (20 μg/kg; minute ventilation, -24 [-53 to 13]%; P = 0.313, compared with the pretreatment level).
CONCLUSIONS:
Repinotan prevented remifentanil-induced ventilatory depression in spontaneously breathing, anesthetized rats. Although repinotan did not depress nociception itself, it prolonged the profound antinociception after discontinuation of remifentanil infusion.
AuthorsUlf Guenther, Nils U Theuerkauf, Daniel Huse, Michael F Boettcher, Georg Wensing, Christian Putensen, Andreas Hoeft
JournalAnesthesiology (Anesthesiology) Vol. 116 Issue 1 Pg. 56-64 (Jan 2012) ISSN: 1528-1175 [Electronic] United States
PMID22082683 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Analgesics, Opioid
  • Anesthetics, Intravenous
  • Benzopyrans
  • Hypnotics and Sedatives
  • Piperidines
  • Serotonin Receptor Agonists
  • Thiazoles
  • Receptor, Serotonin, 5-HT1A
  • repinotan hydrochloride
  • Remifentanil
Topics
  • Analgesics, Opioid (pharmacology)
  • Anesthetics, Intravenous (antagonists & inhibitors, pharmacology, toxicity)
  • Animals
  • Benzopyrans (pharmacology)
  • Blood Pressure (drug effects)
  • Dose-Response Relationship, Drug
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Hypnotics and Sedatives (antagonists & inhibitors, pharmacology, toxicity)
  • Male
  • Pain Measurement (drug effects)
  • Piperidines (antagonists & inhibitors, pharmacology, toxicity)
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT1A (drug effects)
  • Remifentanil
  • Respiratory Insufficiency (chemically induced, prevention & control)
  • Respiratory Mechanics (drug effects)
  • Serotonin Receptor Agonists (pharmacology)
  • Thiazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: